Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-29T17:50:15.034Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of recurrent central nervous system inflammatory myofibroblastic tumor with crizotinib

Published online by Cambridge University Press:  30 October 2014

Philip Wong ,
David Roberge ,
France Berthelet ,
Michel W. Bojanowski ,
Jean-Paul Bahary ,
Laura Masucci ,
Karl Bélanger  and
Marie Florescu
Philip Wong
Affiliation:
Dept. de Radio-Oncologie, CHUM, University of Montreal, Quebec
David Roberge
Affiliation:
Dept. de Radio-Oncologie, CHUM, University of Montreal, Quebec
France Berthelet
Affiliation:
Dept. de Pathologie, CHUM, University of Montreal, Quebec
Michel W. Bojanowski
Affiliation:
Dept. de Neurochirurgie, CHUM, University of Montreal, Quebec
Jean-Paul Bahary
Affiliation:
Dept. de Radio-Oncologie, CHUM, University of Montreal, Quebec
Laura Masucci
Affiliation:
Dept. de Radio-Oncologie, CHUM, University of Montreal, Quebec
Karl Bélanger
Affiliation:
Dept. de Hemato-Oncologie, CHUM, University of Montreal, Quebec
Marie Florescu
Affiliation:
Dept. de Hemato-Oncologie, CHUM, University of Montreal, Quebec
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical Poster Viewing 14 June 2014
Information
Canadian Journal of Neurological Sciences , Volume 41 , Issue s2: 16th Biennial Canadian Neuro-Oncology Meeting , October 2014 , pp. S16
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2014